## Review setup
- **Input scope** Abstract only
- **Assessment boundary** Claims and conclusions as presented in the abstract; no methods, figures, tables, or supplementary material were provided
- **Shared manuscript claim summary** The authors propose a workflow that uses AlphaFold to model reference protein structures and bridge gaps in experimental models, enabling comparative structural analysis of viral proteins whose sequences are not yet experimentally resolved. They state that analyzing flexibility and biochemical properties of regions not captured by experimental methods provides a systematic strategy for refining structural interpretations, functional annotation, and understanding of viral protein interactions and evolution.
- **Visible evidence base** Abstract text only; no experimental data, validation metrics, case studies, or comparative benchmarks are provided
- **Missing materials affecting confidence** Full methods, all figures and tables, validation statistics (e.g., pLDDT scores, RMSD comparisons), any application to specific viral proteins, and comparison with existing structural analysis approaches

## Reviewer
- **Overall assessment** The abstract describes a conceptually reasonable application of AlphaFold to comparative structural analysis of viral proteins, but it is presented at a level of generality that prevents assessment of its technical validity, novelty, or practical utility. The core claims are plausible but unsupported by any visible evidence. The manuscript may have value as a methods protocol within a specialized series, but the abstract alone does not establish a substantive scientific advance.
- **Who would be interested in the results, and why** Computational biologists and virologists working on protein structure prediction, viral evolution, and functional annotation of uncharacterized viral proteins. Researchers applying AlphaFold in comparative frameworks may find the described workflow relevant, particularly those studying structural divergence in rapidly evolving viral populations.
- **Major strengths** The abstract identifies a genuine gap in experimental structural coverage for viral proteins and proposes a reasonable role for AlphaFold in bridging that gap. The emphasis on analyzing flexibility and biochemical properties of regions not captured by experimental methods is a sensible addition that goes beyond simple structure prediction.
- **Major Concerns** The abstract provides no evidence that the proposed workflow has been implemented, validated, or applied to any specific case. The novelty relative to existing AlphaFold-based comparative studies is unclear. The claim that this approach "provides a systematic strategy" is an assertion without demonstration.
- **Minor Comments** The abstract would benefit from specifying the types of viral proteins analyzed, the nature of the comparative framework, and the metrics used to assess structural deviations. The relationship between the proposed workflow and existing tools for structural comparison (e.g., TM-align, FoldSeek) is not addressed.
- **Technical failings that need to be addressed before the case is established** None can be identified from the abstract alone, but the absence of any validation data means the technical soundness of the workflow is entirely unassessed.
- **Assessment against Nature-style criteria** Originality: Low to moderate; applying AlphaFold to comparative viral structural analysis is a natural extension of existing methods. Scientific importance: Moderate; the approach could be useful but is not presented with a specific biological question or demonstrated impact. Interdisciplinary readership: Limited; the abstract is written for a specialist audience familiar with structural biology and viral evolution. Technical soundness: Not assessable from the abstract; no validation or benchmarking is presented. Readability for nonspecialists: Adequate but generic; the abstract uses standard terminology without excessive jargon.
- **Recommendation posture** Currently not established from the provided evidence. The abstract describes a plausible workflow but provides no demonstration of its effectiveness, novelty, or application. A full manuscript with methods, validation, and a concrete case study would be required to assess whether the claims are supported.

### Major Concerns

- **Concern ID** R1-M1
- **Severity** Major
- **Blocking** Yes
- **Axis** Evidence sufficiency
- **Claim pointer** The abstract claims that the described approach "provides a systematic strategy for refining structural interpretations of proteins in evolving viral populations, aiding in functional annotation, and improving our understanding of interactions and evolution of viral proteins."
- **Evidence pointer** Abstract only; location not provided
- **Concern** The central claim of the manuscript is that the proposed AlphaFold-based workflow constitutes a systematic and effective strategy for structural analysis of viral proteins. However, the abstract provides no data, case study, benchmark, or comparative analysis demonstrating that the workflow achieves these outcomes. No specific viral proteins are named, no structural comparisons are shown, and no validation metrics are reported.
- **Why it matters** Without any demonstration of application or validation, the claim that the approach is "systematic" and aids in functional annotation and evolutionary understanding is unsupported. The reader cannot determine whether the workflow produces accurate or useful results, or whether it offers any advantage over existing structural analysis methods.
- **Resolution test** The full manuscript must include at least one concrete application of the workflow to a set of viral proteins, with quantitative validation (e.g., comparison of predicted structures against experimental models where available, assessment of pLDDT confidence, and demonstration that the flexibility and biochemical property analyses yield biologically meaningful insights).

- **Concern ID** R1-M2
- **Severity** Major
- **Blocking** Yes
- **Axis** Novelty and differentiation
- **Claim pointer** The abstract implies that the described approach is a distinct contribution, but it does not specify how it differs from existing AlphaFold-based comparative structural analyses.
- **Evidence pointer** Abstract only; location not provided
- **Concern** The abstract does not reference or differentiate from prior work using AlphaFold for comparative structural analysis, including studies on viral proteins. The claim that this is a "systematic strategy" suggests novelty, but no comparison with existing methods or protocols is provided.
- **Why it matters** If the workflow is essentially a standard application of AlphaFold with routine downstream analysis, its contribution may be limited to a protocol description rather than a scientific advance. The reader cannot assess the incremental value of the work without a clear statement of what is new.
- **Resolution test** The full manuscript must include a literature review and explicit statement of novelty, with a comparison of the proposed workflow against at least one existing approach, demonstrating a specific advantage or distinct application context.

- **Concern ID** R1-M3
- **Severity** Major
- **Blocking** No
- **Axis** Technical detail
- **Claim pointer** The abstract states that regions not captured by experimental methods "are analyzed for their flexibility and biochemical properties" to achieve an accurate depiction of structural changes.
- **Evidence pointer** Abstract only; location not provided
- **Concern** The abstract does not specify how flexibility and biochemical properties are computed or integrated into the structural analysis. No metrics, tools, or thresholds are mentioned. The relationship between these analyses and the AlphaFold predictions is unclear.
- **Why it matters** The methodological basis for the claimed "accurate depiction" is not described. Without specifying the analytical steps, the workflow cannot be reproduced or evaluated, and the claim of accuracy is unsubstantiated.
- **Resolution test** The full manuscript must provide a detailed description of the computational methods used to assess flexibility (e.g., molecular dynamics, B-factor analysis, or disorder prediction) and biochemical properties (e.g., hydrophobicity, charge), including software, parameters, and how these are combined with AlphaFold outputs.

### Minor Comments

- **Concern ID** R1-m1
- **Severity** Minor
- **Axis** Clarity
- **Affected element** Scope specification
- **Evidence pointer** Abstract; location not provided
- **Issue** The abstract does not specify the range of viral proteins or viral families to which the workflow is intended to apply, nor whether it is designed for a particular evolutionary context.
- **Required correction** Add a sentence specifying the intended scope, such as the types of viral proteins (e.g., envelope glycoproteins, polymerases) or the evolutionary timescale of interest.

- **Concern ID** R1-m2
- **Severity** Minor
- **Axis** Reproducibility
- **Affected element** Methodological transparency
- **Evidence pointer** Abstract; location not provided
- **Issue** The abstract does not mention the AlphaFold version, the source of experimental structures used as references, or the criteria for selecting sequences for analysis.
- **Required correction** Include these details in the abstract or indicate that they are provided in the full methods section.

- **Concern ID** R1-m3
- **Severity** Minor
- **Axis** Contextualization
- **Affected element** Related work
- **Evidence pointer** Abstract; location not provided
- **Issue** The abstract does not acknowledge existing computational approaches for studying structural evolution, such as phylogenetic analysis of structures or structural alphabets.
- **Required correction** Add a brief statement situating the proposed workflow within the broader landscape of structural evolutionary analysis.

## Risk / unsupported claims
- The claim that the approach "provides a systematic strategy" is unsupported by any visible evidence in the abstract.
- The claim that the workflow "aids in functional annotation" is not demonstrated.
- The claim that the workflow improves "understanding of interactions and evolution of viral proteins" is not supported by any presented results.
- The assertion that analyzing flexibility and biochemical properties leads to an "accurate depiction of changes in protein structure" is unverifiable without methodological detail and validation.
- The overall utility and novelty of the workflow cannot be assessed from the abstract alone.